Triangle Biotechnology, Inc.
Chapel Hill, NC · Medtech · Private
Levios, a targeted-microbubble technology that enriches pathogenic microorganisms directly from clinical samples to enable rapid molecular diagnostics and antimicrobial resistance characterization
- Grants
- $9.2M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Towards commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | $298,530 | |
| Federal grant | Department of Health and Human Services · Phase I · SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples | $298,529 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Design of custom ultrasonic lens for uniform sonication of biological samples in microplates | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $252,131 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | $1,999,404 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | $1,154,747 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $1,998,364 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $998,364 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of nanodroplet enhanced ultrasonic cavitation technologyto enable the study of chromatin accessibility in FFPE tissues | $339,300 | |
| Federal grant | Department of Health and Human Services · Phase I · SBIR PA22-176 - Culture-free microbial enrichment for diagnosis and characterization of anti-microbial resistance | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Culture-free microbial enrichment for diagnosis and characterization of anti-microbial resistance | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $997,367 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1316 | Etiometry Inc. | — | $8.2M |
| 1317 | AGIL THERAPEUTICS, INC. | — | — |
| 1318 | BennuBio Inc | — | $6.8M |
| 1319 | Triangle Biotechnology, Inc. | — | — |
| 1320 | VitaThreads LLC | — | $175K |
| 1321 | INFER, INC. | — | $33M |
| 1322 | General Fluidics Corporation | — | $31M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Using Nanoparticles And Microparticles For The Disruption And Prevention Of Biofilmsgranted
- Apparatus For Multi-sample Sonication And Related Methodsapplication
- Targeted Nanodroplet And Microbubble Compositions And Methods For Enrichment, Lysis, And Extraction Of Microbial Cellsapplication
- Appratus For Multi-sample Sonication And Related Methodsapplication
- Methods Of Using Nanoparticles And Microparticles For The Disruption And Prevention Of Biofilmsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.